Perrigo Company PLC (N:PRGO)

May 07, 2024 06:31 am ET
Perrigo Reports First Quarter 2024 Financial Results From Continuing Operations
Delivered Adjusted Diluted Earnings Per Share Results Above Projection, Due Primarily to Timing of Infant Formula Shipments; Reaffirm 2024 Financial Outlook
May 07, 2024 06:28 am ET
Perrigo Announces Executive Transition for its Consumer Self-Care International (CSCI) Business
Svend Andersen, EVP and President Consumer Self-Care International (CSCI), to Retire
May 01, 2024 09:42 am ET
Perrigo Announces Quarterly Dividend
DUBLIN, May 1, 2024 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading global provider of Consumer Self-Care Products, today announced that its Board of Directors declared a quarterly dividend of $0.276 per share, payable on June 18, 2024, to shareholders of record on May 31, 2024.
Apr 25, 2024 06:00 am ET
Perrigo Receives Binding Offer to Divest its HRA Pharma Rare Diseases Business for up to €275 Million
Proposed Divestment of Branded Prescription Pharma Business Further Supports Perrigo's Strategic Focus on Consumer Self-Care
Apr 23, 2024 08:09 am ET
Perrigo to Release First Quarter 2024 Financial Results on May 7, 2024
DUBLIN, April 23, 2024 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, today announced that it plans to issue its first quarter 2024 financial results on Tuesday, May 7th, 2024, and host a conference call beginning at 8:30 A.M. (EDT).
Apr 09, 2024 12:30 pm ET
Opill and WNBA Team Up for Groundbreaking Partnership
--The Two Revolutionary Brands Will Redefine Contraception Accessibility--
Feb 27, 2024 05:30 am ET
Feb 26, 2024 03:30 pm ET
Perrigo Increases its Quarterly Dividend
DUBLIN, Feb. 26, 2024 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading global provider of Consumer Self-Care Products, announces that its Board of Directors has approved a 1% increase in the Company's quarterly dividend to $0.276 per share, or $1.10 per share on an annual basis, up from $0.273 per share. This marks the 21st consecutive year Perrigo has increased its dividend.
Feb 13, 2024 07:16 am ET
Perrigo to Release Fourth Quarter and Fiscal Year 2023 Financial Results on February 27, 2024
DUBLIN, Feb. 13, 2024 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, today announced that it plans to issue its fourth quarter and fiscal year 2023 financial results on Tuesday, February 27th, 2024 and will host a conference call beginning at 8:30 A.M. (EST).
Nov 29, 2023 07:54 am ET
Perrigo Announces Early Results of Cash Tender Offer for Notes
DUBLIN, Nov. 29, 2023 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO) (the "Company"), a leading provider of Consumer Self-Care Products, today announced the early tender results of the previously announced cash tender offer (the "Tender Offer") by Perrigo Finance Unlimited Company, its wholly-owned finance subsidiary (the "Issuer"), to purchase its 3.900% Senior Notes due 2024 (CUSIP / ISIN Nos. 714295 AC6 / US714295AC63) (the "Notes") in a principal amount of up to $300,000,000. The terms and conditions of the Tender Offer are set forth in an Offer to Purchase, dated November 10, 2023 (th
Nov 10, 2023 08:16 am ET
Perrigo Announces Cash Tender Offer for Notes
DUBLIN, Nov. 10, 2023 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO) (the "Company"), a leading provider of Consumer Self-Care Products, today announced that Perrigo Finance Unlimited Company, its wholly-owned finance subsidiary (the "Issuer"), commenced a cash tender offer (the "Tender Offer") to purchase its 3.900% Senior Notes due 2024 (CUSIP / ISIN Nos. 714295 AC6 / US714295AC63) (the "Notes") in a principal amount of up to $300,000,000.
Nov 07, 2023 05:30 am ET
Perrigo Reports Third Quarter Fiscal Year 2023 Financial Results From Continuing Operations
Realized Third Quarter Double-Digit Gross Profit, Operating Income and EPS Growth Year-Over-Year
Nov 02, 2023 01:39 pm ET
Perrigo Announces Quarterly Dividend
DUBLIN, Nov. 2, 2023 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading global provider of Consumer Self-Care Products, today announced that its Board of Directors declared a quarterly dividend of $0.273 per share, payable on December 19, 2023, to shareholders of record on December 1, 2023.
Oct 31, 2023 08:54 am ET
Perrigo to Attend Upcoming Consumer Investor Conferences
DUBLIN, Oct. 31, 2023 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, today announced that President and CEO, Patrick Lockwood-Taylor and CFO Eduardo Bezerra are scheduled to participate in one-on-one investor meetings at the Jefferies Consumer Conference in Miami, FL on Wednesday, November 15th, 2023.
Oct 24, 2023 09:54 am ET
Perrigo to Release Third Quarter 2023 Financial Results on November 7, 2023
DUBLIN, Oct. 24, 2023 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, today announced that it plans to issue its third quarter 2023 financial results on Tuesday, November 7, 2023, and will host a conference call beginning at 8:30 A.M. (EST).
Sep 11, 2023 04:05 pm ET
Perrigo Announces Leadership Update
Appoints Experienced Consumer Packaged Goods Executive Catherine "Triona" Schmelter as EVP and President, Consumer Self-Care Americas (CSCA) and Global Portfolio Optimization
Aug 02, 2023 10:19 am ET
PERRIGO ANNOUNCES QUARTERLY DIVIDEND
DUBLIN, Ireland, Aug. 2, 2023 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading global provider of Consumer Self-Care Products, today announced that its Board of Directors declared a quarterly dividend of $0.273 per share, payable on September 19, 2023, to shareholders of record on September 1, 2023.
Jul 25, 2023 09:31 am ET
Perrigo to Release Second Quarter 2023 Financial Results and Present at an Industry Growth Conference
DUBLIN, July 25, 2023 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, today announced that it plans to issue its second quarter 2023 financial results on Tuesday, August 8, 2023, and will host a conference call beginning at 8:30 A.M. (EST).
Jul 13, 2023 08:38 am ET
Perrigo Announces U.S. FDA Approval for Opill® OTC Daily Oral Contraceptive
DUBLIN, July 13, 2023 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, announced today that the U.S. Food and Drug Administration (FDA) approved Opill®, a progestin-only daily oral contraceptive, for over-the-counter (OTC) use for all ages. Opill® is the first ever birth control pill available over the counter in the United States.
Jun 08, 2023 07:40 am ET
Perrigo Appoints Patrick Lockwood-Taylor as President and CEO
DUBLIN, June 8, 2023 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, today announced the appointment of industry professional Patrick Lockwood-Taylor as its new President, Chief Executive Officer and member of the Board of Directors, effective June 30, 2023.
May 24, 2023 09:09 am ET
Perrigo to Host 1x1 Investor Meetings at the 23rd Annual Oppenheimer Consumer Growth & E-Commerce Conference
DUBLIN, May 24, 2023 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, today announced that it is scheduled to host 1x1 investor meetings at the Oppenheimer 23rd Annual Consumer Growth & E-Commerce Conference, being conducted virtually on Tuesday, June 13th.  
May 16, 2023 10:20 am ET
May 16, 2023 09:02 am ET
PERRIGO ANNOUNCES U.S. FDA APPROVAL FOR NICOTINE COATED MINT LOZENGE
DUBLIN, May 16, 2023 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, today announced that it has received final approval from the U.S. Food and Drug Administration for Nicotine Coated Mint Lozenges, 2 mg and 4 mg over-the-counter (OTC).
May 10, 2023 01:40 pm ET
FDA Joint Advisory Committee Votes in Favor of Perrigo's Opill® Daily Oral Contraceptive for OTC Use
DUBLIN, May 10, 2023 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, announced today that the U.S. Food and Drug Administration's (FDA) Nonprescription Drugs Advisory Committee (NDAC) and the Obstetrics, Reproductive, and Urologic Drugs Advisory Committee (ORUDAC) voted unanimously 17 to 0, with no abstentions, that the benefits of making Opill®, a progestin-only daily oral contraceptive, available for over-the-counter (OTC) use outweighs the risks. The joint committee's vote, while not binding, will be considered by the FDA when making it
May 09, 2023 06:32 am ET
May 09, 2023 06:30 am ET
Perrigo Announces Chief Executive Officer Retirement and Succession Plan
DUBLIN, May 9, 2023 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, today announced that Murray S. Kessler has notified the Company of his intent to retire as President and Chief Executive Officer, with a target effective date of July 31, 2023. Mr. Kessler will be working with the Board of Directors to secure his successor and to ensure a smooth transition.
May 04, 2023 08:23 am ET
PERRIGO ANNOUNCES QUARTERLY DIVIDEND
DUBLIN, May 4, 2023 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading global provider of Consumer Self-Care Products, today announced that its Board of Directors declared a quarterly dividend of $0.273 per share, payable on June 20, 2023, to shareholders of record on June 2, 2023.
Apr 25, 2023 09:18 am ET
Perrigo to Release First Quarter 2023 Financial Results on May 9, 2023
DUBLIN, April 25, 2023 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, today announced that it plans to issue its first quarter 2023 results on Tuesday, May 9, 2023. The Company will also host a conference call beginning at 8:30 A.M. (EST).
Apr 06, 2023 08:00 am ET
Firefly® Expands Its Commitment to Sustainability with Free Recycling Program
Brand Partners with TerraCycle® to Offer Consumers Way to Recycle Product Waste
Mar 28, 2023 08:58 am ET
Perrigo Announces New Date for Joint FDA Advisory Committee Meeting to Review Opill® Daily Oral Contraceptive for OTC Use
DUBLIN, March 28, 2023 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, today announced that the U.S. Food and Drug Administration (FDA) has rescheduled a joint meeting of the Nonprescription Drugs Advisory Committee (NDAC) and the Obstetrics, Reproductive, and Urologic Drugs Advisory Committee (ORUDAC) for May 9 & 10, 2023, to review the Company's application for Opill® daily oral contraceptive for over-the-counter (OTC) use.
Feb 27, 2023 03:58 pm ET
Dec 19, 2022 08:00 am ET
Perrigo to Host Virtual Investor Day on February 28, 2023
DUBLIN, Dec. 19, 2022 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading global provider of Consumer Self-Care Products, today announced that it will host a Virtual Investor Day on February 28, 2023, in conjunction with its regular quarterly earnings. At that meeting, management will share the Company's 2023-2025 strategic plans to Optimize and Accelerate the performance of the recently transformed Company through a continuation of strong net sales and market share growth, a global supply chain initiative designed to substantively increase gross margins, a focus on cash generation a
Dec 16, 2022 09:00 am ET
SWEDEN’S SKINCARE SENSATION ACO EXTENDS PRESENCE INTO US TIMED TO THE HOLIDAY SEASON
When it comes to natural beauty, Sweden is notorious - so it’s no surprise that the Nordic country is also ripe with natural ingredients that lend to premium skincare products. Introducing ACO - the Stockholm based Scandinavian skincare staple...
Nov 08, 2022 05:30 am ET
Nov 03, 2022 12:00 pm ET
Perrigo Announces Quarterly Dividend
DUBLIN, Nov. 3, 2022 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading global provider of Consumer Self-Care Products, today announced that its Board of Directors declared a quarterly dividend of $0.26 per share, payable on December 20, 2022, to shareholders of record on December 2, 2022.
Nov 01, 2022 04:01 pm ET
Perrigo Announces Strategic Investment to Expand and Strengthen U.S. Manufacturing of Infant Formula
Company Purchases Nestlé's Gateway Infant Formula Plant in Eau Claire, Wisconsin, along with U.S. and Canadian rights to the Good Start® Infant Formula Brand
Nov 01, 2022 04:01 pm ET
Perrigo Announces Strategic Investment to Expand and Strengthen U.S. Manufacturing of Infant Formula
Company Purchases Nestlé's Gateway Infant Formula Plant in Eau Claire, Wisconsin, along with U.S. and Canadian rights to the Good Start® Infant Formula Brand
Oct 26, 2022 08:30 am ET
Perrigo Receives Notification of Postponement for Joint FDA Advisory Committee to Review Opill® Daily Oral Contraceptive for Over-The-Counter (OTC) Use
DUBLIN, Oct. 26, 2022 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO) ("Perrigo" or "the Company"), a leading provider of Consumer Self-Care Products, today announced that it has received notification that the U.S. Food and Drug Administration (FDA) has postponed the joint meeting of the Nonprescription Drugs Advisory Committee and the Obstetrics, Reproductive and Urologic Drugs Advisory Committee, previously planned for November 18, 2022, to discuss the Company's application for Opill® once daily oral contraceptive for OTC use. The rescheduled date for the joint advisory committee meeting
Oct 25, 2022 05:20 pm ET
Perrigo to Release Third Quarter 2022 Financial Results on November 8, 2022
DUBLIN, Oct. 25, 2022 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, today announced that it will release its third quarter 2022 financial results on Tuesday, November 8, 2022. The Company will also host a conference call beginning at 8:30 A.M. (EST).
Sep 12, 2022 09:32 am ET
PERRIGO ANNOUNCES JOINT FDA ADVISORY COMMITTEE TO REVIEW OPILL® DAILY ORAL CONTRACEPTIVE FOR OVER-THE-COUNTER (OTC) USE
DUBLIN, Sept. 12, 2022 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, today announced that the U.S. Food and Drug Administration (FDA) has scheduled a joint meeting of the Nonprescription Drugs Advisory Committee (NDAC) and the Obstetrics, Reproductive, and Urologic Drugs Advisory Committee (ORUDAC) on November 18, 2022, to review the Company's application for Opill® daily oral contraceptive for OTC use.
Aug 17, 2022 04:23 pm ET
PERRIGO RELEASES STATEMENT ON RECENT MARKET TRADING ACTIVITY
DUBLIN, Aug. 17, 2022 /PRNewswire/ -- In response to speculative commentary regarding ranitidine (Zantac®) litigation from a news story that contained certain misleading and inaccurate information, Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, today issued the following statement:
Aug 09, 2022 06:30 am ET
Aug 02, 2022 09:20 am ET
PERRIGO ANNOUNCES QUARTERLY DIVIDEND
DUBLIN, Aug. 2, 2022 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading global provider of Consumer Self-Care Products, today announced that its Board of Directors declared a quarterly dividend of $0.26 per share, payable on September 20, 2022, to shareholders of record on September 2, 2022.
Jul 27, 2022 08:13 am ET
PERRIGO TO RELEASE SECOND QUARTER 2022 FINANCIAL RESULTS ON AUGUST 9, 2022
DUBLIN , July 27, 2022 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, today announced that it will release its second quarter 2022 financial results on Tuesday, August 9, 2022. The Company will also host a conference call beginning at 8:30 A.M. (EDT).
Jul 11, 2022 06:00 am ET
Perrigo's HRA Pharma Submits Application to FDA for First-Ever OTC Birth Control Pill
DUBLIN and ALLEGAN, Mich., July 11, 2022 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading global provider of Consumer Self-Care Products, today announced that HRA Pharma, a Perrigo company, has submitted its application to the United States Food and Drug Administration (FDA) for the first-ever over-the-counter (OTC) birth control pill in the United States.
Jun 01, 2022 08:30 am ET
PERRIGO PROMOTES ALISON IVES TO ROLE OF CHIEF SCIENTIFIC OFFICER
DUBLIN, June 1, 2022 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO) today announced that Ms. Alison Ives has been promoted to Executive Vice President and Chief Scientific Officer. In this role, Ms. Ives will be responsible for providing global oversight and coordination of Perrigo's research and development, regulatory and innovation efforts. She will join the Company's Operating Committee and report to President and Chief Executive Officer, Murray S. Kessler.
May 26, 2022 09:17 am ET
PERRIGO ANNOUNCES U.S. FDA APPROVAL FOR OMEPRAZOLE MAGNESIUM DELAYED-RELEASE MINI CAPSULES
DUBLIN, May 26, 2022 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, today announced that it has received final approval from the U.S. Food and Drug Administration for Omeprazole Magnesium Delayed-Release Mini Capsules, 20 mg over-the-counter (OTC). Perrigo expects to launch Omeprazole Minis later this year.
May 19, 2022 08:43 am ET
PERRIGO TO PRESENT AT UPCOMING CONSUMER INVESTOR CONFERENCES
DUBLIN, May 19, 2022 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, today announced that President and CEO, Murray S. Kessler and CFO Eduardo Bezerra are scheduled to participate in investor meetings at the Credit Suisse HALO Investment Summit held in New York City on Wednesday, May 25th. There will be no formal presentation.
May 11, 2022 06:21 am ET
PERRIGO ANNOUNCES PLANNED LEADERSHIP SUCCESSION
Mr. Eduardo G. Bezerra named EVP, Chief Financial Officer
May 05, 2022 08:36 am ET
PERRIGO ANNOUNCES QUARTERLY DIVIDEND
DUBLIN, May 5, 2022 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading global provider of Consumer Self-Care Products, today announced that its Board of Directors declared a quarterly dividend of $0.26 per share, payable on June 21, 2022, to shareholders of record on June 3, 2022.
May 02, 2022 07:30 am ET
PERRIGO COMPLETES THE ACQUISITION OF HRA PHARMA
DUBLIN, May 2, 2022 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, today announced that on April 29, 2022 it completed the previously announced acquisition of Héra SAS ("HRA") for €1.8 billion, or approximately $1.9 billion based on current exchange rates, in cash, accelerating its position as a leading global consumer self-care company.
Apr 28, 2022 04:30 pm ET
PERRIGO ANNOUNCES EXPECTED TRANSACTION CLOSE DATE OF HRA PHARMA
DUBLIN, April 28, 2022 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, today announced that the closing date of the previously announced acquisition of Héra SAS ("HRA" or "HRA Pharma") is expected to occur on April 29, 2022, subject to the satisfaction or waiver of the remaining closing conditions set forth in the securities sale agreement.
Apr 27, 2022 09:03 am ET
PERRIGO TO RELEASE FIRST QUARTER 2022 FINANCIAL RESULTS ON MAY 11, 2022
DUBLIN, April 27, 2022 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, today announced that it will release its first quarter 2022 financial results on Wednesday, May 11, 2022. The Company will also host a conference call beginning at 8:30 A.M. (EDT).
Apr 20, 2022 04:15 pm ET
PERRIGO ANNOUNCES CLOSING OF $2.6 BILLION SENIOR SECURED CREDIT FACILITIES
DUBLIN, April 20, 2022 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO) ("Perrigo" or the "Company"), a leading provider of Consumer Self-Care Products, today announced that it closed its previously announced senior secured credit facilities. The new facilities consist of (i) a $1.0 billion five-year revolving credit facility (the "New Revolving Facility"), (ii) a $500 million five-year term loan A facility (the "New Term Loan A Facility"), and (iii) a $1.1 billion seven-year term loan B facility (the "New Term Loan B Facility" and, together with the New Term Loan A Facility, the "New Term L
Apr 04, 2022 07:30 am ET
PERRIGO ANNOUNCES LAUNCH OF PRIVATE NOTES OFFERING
DUBLIN, April 4, 2022 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO) ("Perrigo" or the "Company"), a leading provider of Quality, Affordable Self-Care Products, today announced that it has launched a private offering (the "Offering") of $500 million aggregate principal amount of senior notes due 2030 (the "Notes"), subject to market and other conditions, through its indirect wholly-owned subsidiaries, Perrigo Investments, LLC and Perrigo Investments Capital, Inc. (together, the "Issuers").
Mar 28, 2022 07:30 am ET
PERRIGO ANNOUNCES LAUNCH OF SYNDICATION OF NEW SENIOR SECURED CREDIT FACILITIES
DUBLIN, March 28, 2022 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO) ("Perrigo" or the "Company"), a leading provider of Quality, Affordable Self-Care Products, today announced that it has launched the syndication of new senior secured credit facilities expected to consist of (i) a $1,000 million five-year revolving credit facility (the "New Revolving Facility") and (ii) a $300 million five-year term loan A facility and a $800 million seven-year term loan B facility (the "New Term Loan Facilities" and, together with the New Revolving Facility, the "New Senior Secured Credit Facilities") t
Mar 24, 2022 04:22 pm ET
PERRIGO ANNOUNCES CFO RETIREMENT AND TRANSITION PLAN
DUBLIN, March 24, 2022 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, today announced the planned retirement of Ray Silcock, Executive Vice President and Chief Financial Officer, who will remain with the company in his current position until July 15, 2022. The Company has initiated a comprehensive search with the assistance of a leading executive search firm to identify a successor for this position.
Mar 10, 2022 07:22 am ET
PERRIGO COMPLETES DIVESTITURE OF LATIN AMERICAN BUSINESSES
DUBLIN, March 10, 2022 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of Quality Affordable Self-Care Products, today announced that it has completed the previously announced sale of its Mexico and Brazil-based over-the-counter (OTC) businesses to Advent International. This transaction is part of Perrigo's margin improvement program and Project Momentum cost savings initiative. Financial terms were not disclosed.  
Mar 01, 2022 06:00 am ET
Feb 25, 2022 07:16 am ET
PERRIGO TO PRESENT AT UPCOMING INVESTOR CONFERENCES
DUBLIN, Feb. 25, 2022 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO) today announced that President and CEO, Murray S. Kessler and CFO Ray Silcock are scheduled to present at the Raymond James 43rd Annual Institutional Investors Conference at 11:00 AM EST on Tuesday, March 8th in Orlando, Florida.
Feb 03, 2022 08:05 am ET
Perrigo Expands Occupational Health Program with Premise Health's Digital Wellness Center
BRENTWOOD, Tenn., Feb. 3, 2022 /PRNewswire/ -- Premise Health, the largest direct health care provider and an OMERS portfolio company, is partnering with Perrigo Company plc (NYSE, TASE: PRGO) to expand the company's occupational health and safety program to its employees outside of Michigan with the addition of virtual occupational health services starting this month. Falling under Premise's Digital Wellness Center, virtual occupational health is a digital option available 24/7 to both remote and on-site employees wherever and whenever they need access to high-quality occupational health ca
Jan 04, 2022 06:59 am ET
PERRIGO TO PRESENT VIRTUALLY AT THE 40th ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
DUBLIN, Jan. 4, 2022 /PRNewswire/ -- Perrigo Company plc (NYSE; TASE: PRGO), announced today that President and CEO, Murray S. Kessler is scheduled to present virtually at the 40th Annual J.P. Morgan Healthcare Conference on Wednesday, January 12, 2022 at 3:45 PM (EST).   
Sep 30, 2021 09:31 am ET
Thinking about trading options or stock in Perrigo Company, Thor Industries, CarMax, Apple, or Nio?
NEW YORK, Sept. 30, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for PRGO, THO, KMX, AAPL, and NIO.
Sep 03, 2021 06:55 pm ET
Match Group, Ceridian HCM and Brown & Brown Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600
NEW YORK, Sept. 3, 2021 /PRNewswire/ -- S&P Dow Jones Indices will make the following index adjustments to the S&P 500, S&P MidCap 400, and S&P SmallCap 600 to ensure each index is more representative of its market capitalization range. The changes will be effective prior to the open of trading on Monday, September 20, 2021 to coincide with the quarterly rebalance:
Jul 14, 2021 09:31 am ET
Thinking about trading options or stock in Apple, Boeing, Perrigo, Mastercard, or Microsoft?
NEW YORK, July 14, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for AAPL, BA, PRGO, MA, and MSFT.
Feb 16, 2021 07:09 am ET
Perrigo To Release Fourth Quarter And Calendar Year 2020 Financial Results On March 1, 2021
DUBLIN, Feb. 16, 2021 /PRNewswire/ -- Perrigo Company plc (NYSE; TASE: PRGO) today announced that it will release its fourth quarter and calendar year 2020 financial results on Monday, March 1, 2021. The Company will also host a conference call beginning at 8:00 a.m. (EST).
Jan 11, 2021 07:00 am ET
Perrigo And Michigan State University Announce Partnership To Advance Consumer Self-Care Innovation
DUBLIN and GRAND RAPIDS, Mich., Jan. 11, 2021 /PRNewswire/ -- Perrigo Company plc (NYSE; TASE: PRGO), a leading provider of Quality, Affordable Self-Care Products, announced today a formal partnership with Michigan State University (MSU), connecting the university's clinical and research expertise with Perrigo's product innovation, manufacturing scale and retail partnerships to empower consumers to take control of their self-care needs.
Dec 17, 2020 07:03 am ET
Perrigo to Present Virtually at Upcoming Investor Conferences
DUBLIN, Dec. 17, 2020 /PRNewswire/ -- Perrigo Company plc (NYSE; TASE: PRGO), today announced that EVP and President of Consumer Self-Care Americas, Rich Sorota will present at the ICR Conference at 11:30 AM EST on Monday, January 11, 2021.
Nov 17, 2020 07:15 am ET
Perrigo To Present At The Morgan Stanley Global Consumer & Retail Conference
DUBLIN, Nov. 17, 2020 /PRNewswire/ -- Perrigo Company plc (NYSE; TASE: PRGO), today announced that CEO and President, Murray S. Kessler and CFO, Ray Silcock, will present at the Morgan Stanley Global Consumer & Retail Conference at 1:00 PM EST on Tuesday, December 1, 2020.  Interested parties can access the presentation webcasts at http://perrigo.investorroom.com/events-webcasts.
Nov 12, 2020 07:05 am ET
Sol-Gel Technologies Reports Third Quarter 2020 Financial Results and Corporate Update
Sol-Gel Technologies, Ltd. (NASDAQ: SLGL), a clinical-stage dermatology company focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases, today announced financial results...
Nov 04, 2020 03:01 pm ET
Perrigo Reports Third Quarter 2020 Financial Results
DUBLIN, Nov. 4, 2020 /PRNewswire/ -- Perrigo Company plc (NYSE; TASE: PRGO), a leading provider of Quality, Affordable Self-Care Products, today announced financial results for the third quarter ended September 26, 2020.
Nov 04, 2020 04:18 am ET
Irish High Court Rules Perrigo's Legitimate Expectations Not Violated; Company Remains Committed To Vigorously Challenging The Notice Of Amended Assesment
DUBLIN, Nov. 4, 2020 /PRNewswire/ -- Perrigo Company plc (NYSE; TASE: PRGO) today announced that the Irish High Court, which is a court of first instance, ruled that the issuance of the Notice of Amended Assessment by Irish Revenue in November 2018 did not violate the Company's legitimate expectations. No payment is required as a result of this ruling.
Nov 02, 2020 08:46 am ET
Travel Safely with Steripod® this Holiday Season
ALLEGAN, Mich., Nov. 2, 2020 /PRNewswire/ -- The holiday season feels a bit different this year as families around the world determine if they will meet in-person or virtually to celebrate. Steripod, a Perrigo Company plc (NYSE; TASE: PRGO) brand, is encouraging those who travel to see loved ones to help protect against illness, and harmful bacteria and viruses such as COVID-19, by taking extra safety precautions like protecting their oral care equipment.
Oct 29, 2020 04:15 pm ET
Perrigo Updates Earnings Conference Call Timing Scheduled For November 4, 2020, Due To Notification Of Judical Review Decision
DUBLIN, Oct. 29, 2020 /PRNewswire/ -- Perrigo Company plc (NYSE; TASE: PRGO), a leading provider of Quality, Affordable Self-Care Products, today announced that it has been advised by the Irish High Court that the Court's decision on our pending Judicial Review case on whether to invalidate the Notice of Amended Assessment issued by Irish Revenue will be delivered sometime on November 4, 2020. As a result, the Company will move its third quarter financial results call to 4:30 p.m. (EST) on Wednesday, November 4, 2020 from its previously scheduled call time of 8:00 a.m.
Oct 22, 2020 10:37 am ET
Perrigo Announces Quarterly Dividend
DUBLIN, Oct. 22, 2020 /PRNewswire/ -- Perrigo Company plc (NYSE; TASE: PRGO), a leading global provider of Quality, Affordable Self-Care Products, today announced that its Board of Directors declared a quarterly dividend of $0.225 per share, payable on December 15, 2020 to shareholders of record on November 27, 2020.
Oct 14, 2020 08:15 am ET
Perrigo To Release Third Quarter 2020 Financial Results On November 4, 2020
DUBLIN, Oct. 14, 2020 /PRNewswire/ -- Perrigo Company plc (NYSE; TASE: PRGO), a leading provider of Quality, Affordable Self-Care Products, today announced that it will release its third quarter financial results on Wednesday, November 4, 2020. The Company will also host a conference call beginning at 8:00 a.m. (EST).
Sep 03, 2020 07:05 am ET
Sol-Gel Technologies Collaboration Partner Filed First-to-File Paragraph IV Certification for Duobrii®
Sol-Gel Technologies, Ltd. (NASDAQ: SLGL), a clinical-stage dermatology company focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases, today announced that Bausch Health...
Aug 06, 2020 07:08 am ET
Sol-Gel Technologies Reports Second Quarter 2020 Financial Results and Corporate Update
Sol-Gel Technologies, Ltd. (NASDAQ: SLGL), a clinical-stage dermatology company focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases, today announced financial results...
Aug 05, 2020 07:00 am ET
Perrigo Company plc Reports Second Quarter 2020 Financial Results
DUBLIN, Aug. 5, 2020 /PRNewswire/ -- Perrigo Company plc (NYSE; TASE: PRGO), a leading provider of Quality, Affordable Self-Care Products, today announced financial results for the second quarter ended June 27, 2020.
Jul 29, 2020 02:00 pm ET
Perrigo Announces Quarterly Dividend
DUBLIN, July 29, 2020 /PRNewswire/ -- Perrigo Company plc (NYSE; TASE: PRGO), a leading global provider of Quality, Affordable Self-Care Products, today announced that its Board of Directors declared a quarterly dividend of $0.225 per share, payable on September 15, 2020 to shareholders of record on August 28, 2020.
Jul 15, 2020 08:32 am ET
Perrigo To Release Second Quarter 2020 Financial Results On August 5, 2020
DUBLIN, July 15, 2020 /PRNewswire/ -- Perrigo Company plc (NYSE; TASE: PRGO), a leading provider of Quality, Affordable Self-Care Products, today announced that it will release its second quarter financial results on Wednesday, August 5, 2020. The Company will also host a conference call beginning at 9:00 a.m. (EDT).
Jun 29, 2020 07:00 am ET
Sol-Gel Technologies Announces Agreements with Perrigo Company for Three New Generic Product Candidates
Sol-Gel Technologies, Ltd. (NASDAQ: SLGL), a clinical-stage dermatology company focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases, today announced that it has entered...
Jun 19, 2020 02:03 pm ET
Perrigo Announces The Closing Of A Senior Notes Offering By Its Finance Subsidiary, Perrigo Finance Unlimited Company
DUBLIN, June 19, 2020 /PRNewswire/ -- Perrigo Company plc ("Perrigo" or the "Company") (NYSE; TASE: PRGO) today announced the closing of the previously announced registered public offering by Perrigo Finance Unlimited Company, an indirect wholly-owned finance subsidiary of Perrigo (the "Issuer"), of $750.0 million aggregate principal amount of the Issuer's 3.150% Senior Notes due 2030 (the "Notes"). The Notes will be fully and unconditionally guaranteed on a senior unsecured basis by Perrigo.
Jun 19, 2020 08:05 am ET
Perrigo Furthers Its Consumer-Focused Transformation By Divesting Its U.K. Generic Prescription Pharmaceuticals Business For £156 Million Or Approximately $195 Million
DUBLIN, June 19, 2020 /PRNewswire/ -- Perrigo Company plc (NYSE; TASE: PRGO) today announced that it has reached a definitive agreement to sell its U.K.-based Rosemont Pharmaceuticals business, a generic prescription pharmaceuticals manufacturer focused on liquid medicines, to a U.K.-headquartered private equity firm for £156 million or approximately $195 million in cash. This transaction, which was signed and closed on the same day, represents another step in Perrigo's transformation to a consumer-focused self-care company.  
Jun 17, 2020 08:20 am ET
Perrigo Partners With Kazmira LLC To Enter CBD Market Through A Two-Phased, Science-Based Approach
DUBLIN, June 17, 2020 /PRNewswire/ -- Perrigo Company plc (NYSE; TASE: PRGO), a leading global provider of Quality, Affordable Self-Care Products, announced today that it is entering the cannabidiol ("CBD") market through a strategic investment in and long-term supply agreement with Kazmira LLC, a leading supplier of hemp-based CBD products free of tetrahydrocannabinol ("THC-free") based in Watkins, Colorado. The fast-growing and rapidly evolving CBD market is emerging organically in response to changing consumer preferences for natural remedies and aligns with Perrigo's vision "To make live
Jun 16, 2020 04:11 pm ET
Perrigo Announces The Pricing Of A Senior Notes Offering By Its Finance Subsidiary, Perrigo Finance Unlimited Company
DUBLIN, June 16, 2020 /PRNewswire/ -- Perrigo Company plc ("Perrigo" or the "Company") (NYSE; TASE: PRGO), a leading global provider of Quality, Affordable Self-Care Products, today announced the pricing of a previously announced registered public offering by Perrigo Finance Unlimited Company, an indirect wholly-owned finance subsidiary of Perrigo (the "Issuer"), of $750 million aggregate principal amount of the Issuer's 3.150% Senior Notes due 2030 (the "Notes"). The Notes will be fully and unconditionally guaranteed on a senior unsecured basis by Perrigo. The Notes were sold at a public of
Jun 16, 2020 09:10 am ET
Perrigo Announces Proposed Public Offering Of Senior Notes Of Its Finance Subsidiary, Perrigo Finance Unlimited Company
DUBLIN, June 16, 2020 /PRNewswire/ -- Perrigo Company plc ("Perrigo" or the "Company") (NYSE; TASE: PRGO), a leading global provider of Quality, Affordable Self-Care Products, today announced that Perrigo Finance Unlimited Company, an indirect wholly-owned finance subsidiary of Perrigo (the "Issuer"), commenced a registered public offering of senior notes (the "Notes"). The Notes will be fully and unconditionally guaranteed on a senior unsecured basis by the Company. The exact terms and timing of the offering will depend upon market conditions and other factors.
Jun 02, 2020 04:14 pm ET
Perrigo To Present At The 20th Annual Oppenheimer Consumer Growth & E-Commerce Virtual Conference
DUBLIN, Ireland, June 2, 2020 /PRNewswire/ -- Perrigo Company plc (NYSE; TASE: PRGO) today announced that President and CEO Murray S. Kessler will present further details on the Company's consumer growth strategy along with a general update on the business at the 20th Annual Oppenheimer Consumer Growth and E-Commerce Virtual Conference at 2:00 PM EDT on Wednesday, June 17, 2020. Interested parties can access the presentation webcast at http://perrigo.investorroom.com/events-webcasts.
Jun 02, 2020 09:55 am ET
Perrigo Donates 160,000 Toothbrushes to West Michigan Nonprofit Organizations
GRAND RAPIDS, Mich., June 2, 2020 /PRNewswire/ -- As organizations struggle to meet increased demand for charitable relief during the COVID-19 pandemic, Perrigo Company is donating more than 160,000 toothbrushes to Camp Fire West Michigan, The StoreHouse of Community Resources and Kids Food Basket. The donation, which is valued at approximately $150,000, is intended to provide healthy oral care tools to those who have limited access to new toothbrushes or are not performing routine brushing, as a result of pandemic shopping challenges.  
May 08, 2020 02:25 pm ET
Perrigo To Present At The RBC Capital Markets Global Healthcare Conference
DUBLIN, May 8, 2020 /PRNewswire/ -- Perrigo Company plc (NYSE; TASE: PRGO) today announced that President and CEO Murray S. Kessler will host a fireside chat at the RBC Capital Markets Global Healthcare Conference at 11:30 AM EDT on Wednesday, May 20, 2020. Interested parties can access the presentation webcast at http://perrigo.investorroom.com/events-webcasts.
May 05, 2020 04:21 pm ET
Perrigo Announces Quarterly Dividend
DUBLIN, May 5, 2020 /PRNewswire/ -- Perrigo Company plc (NYSE; TASE: PRGO), a leading global provider of Quality, Affordable Self-Care Products, today announced that its Board of Directors declared a quarterly dividend of $0.225 per share, payable on June 16, 2020 to shareholders of record on May 29, 2020.
May 05, 2020 04:08 pm ET
Perrigo To Present At The Goldman Sachs Global Staples Forum Webcast
DUBLIN, May 5, 2020 /PRNewswire/ -- Perrigo Company plc (NYSE; TASE: PRGO) today announced that President and CEO Murray S. Kessler will present as part of the Goldman Sachs Global Staples Forum Webcast at 8:10 AM EST on Monday, May 18, 2020. Interested parties can access the presentation webcast at http://perrigo.investorroom.com/events-webcasts.
Apr 30, 2020 06:30 am ET
Perrigo Company plc Reports First Quarter 2020 Financial Results
DUBLIN, April 30, 2020 /PRNewswire/ -- Perrigo Company plc (NYSE; TASE: PRGO) today announced financial results for the first quarter ended March 28, 2020.
Apr 22, 2020 04:18 pm ET
Perrigo Announces Change of Venue and Time of the Annual General Meeting to be Held on Wednesday, May 6, 2020 and Measures to Minimise Any Risk of Coronavirus (COVID-19) Transmission
DUBLIN, April 22, 2020 /PRNewswire/ -- The Perrigo Company plc (NYSE; TASE: PRGO) Board of Directors considers the well-being of shareholders, employees and service providers at the upcoming Annual General Meeting ("AGM") a primary concern and, in this context, has been closely monitoring developments in relation to the Coronavirus (COVID-19).
Apr 16, 2020 08:03 am ET
Perrigo to Release First Quarter 2020 Financial Results on April 30, 2020
DUBLIN, April 16, 2020 /PRNewswire/ -- Perrigo Company plc (NYSE; TASE: PRGO) today announced that it will release its first quarter financial results on Thursday, April 30, 2020. The Company will also host a conference call beginning at 8:30 a.m. (EST).
Apr 07, 2020 04:50 pm ET
Perrigo Announces Preliminary Unaudited First Quarter 2020 Net Sales And Provides First Quarter Operating Income Range
DUBLIN, April 7, 2020 /PRNewswire/ -- Perrigo Company plc (NYSE; TASE: PRGO) announced today preliminary unaudited first quarter 2020 net sales and provided GAAP and non-GAAP operating income for the first quarter.
Apr 06, 2020 08:30 am ET
Perrigo Announces FDA Approval for the Store Brand Equivalent of Voltaren® Arthritis Pain
DUBLIN, April 6, 2020 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO; TASE) today announced that it was the first to receive approval from the U.S. Food and Drug Administration for its abbreviated new drug application (ANDA) for over-the-counter ("OTC") diclofenac sodium topical gel 1%. On February 14, 2020, the FDA approved Voltaren® Arthritis Pain (diclofenac sodium topical gel, 1%) for nonprescription or OTC, use through its prescription (Rx)-to-OTC switch process.
Apr 02, 2020 08:30 am ET
Perrigo Completes Acquisition of Oral Care Assets of High Ridge Brands
DUBLIN, April 2, 2020 /PRNewswire/ -- Perrigo Company plc (NYSE; TASE: PRGO) announced today that it has completed the acquisition of the oral self-care assets of High Ridge Brands. The acquisition underscores the numerous bolt-on opportunities that are advancing Perrigo's commitment to transform to a global consumer-focused self-care company and build shareholder value.
Nov 13, 2019 08:29 am ET
Perrigo to Present at the Morgan Stanley Global Consumer & Retail Conference
DUBLIN, Nov. 13, 2019 /PRNewswire/ -- Perrigo Company plc (NYSE; TASE: PRGO), today announced that CEO and President, Murray S. Kessler and CFO, Ray Silcock, will present at the Morgan Stanley Global Consumer & Retail Conference at 10:00 AM EST on Wednesday, December 4, 2019.  Interested parties can access the presentation webcasts at http://perrigo.investorroom.com/events-webcasts.
Nov 06, 2019 05:00 am ET
Perrigo Company plc Reports Third Quarter 2019 Financial Results
DUBLIN, Nov. 6, 2019 /PRNewswire/ -- Perrigo Company plc (NYSE; TASE: PRGO), a leading global provider of "Quality, Affordable Self-Care ProductsTM", today announced financial results for the third quarter ended September 28, 2019.
Nov 04, 2019 08:31 am ET
Perrigo Announces Quarterly Dividend
DUBLIN, Nov. 4, 2019 /PRNewswire/ -- Perrigo Company plc (NYSE; TASE: PRGO), a leading global provider of "Quality, Affordable Self-care Products™", today announced that its Board of Directors declared a quarterly dividend of $0.21 per share, payable on December 17, 2019 to shareholders of record on November 29, 2019.
Oct 23, 2019 04:06 pm ET
Perrigo Company plc Issues Voluntary Worldwide Recall of Ranitidine Due to Possible Presence of Impurity, N-nitrosodimethylamine (NDMA) Impurity in the product
DUBLIN, Oct. 23, 2019 /PRNewswire/ -- As a precautionary measure, Perrigo Company plc (NYSE; TASE: PRGO) announced today that it has initiated a voluntary, worldwide product recall to the retail customer level of ranitidine (all pack sizes). The recall is being taken due to possible presence of a nitrosamine impurity called N-nitrosodimethylamine (NDMA).  
Oct 15, 2019 08:05 am ET
Perrigo Announces Third Quarter Calendar Year 2019 Earnings Date
DUBLIN, Oct. 15, 2019 /PRNewswire/ -- Perrigo Company plc (NYSE; TASE: PRGO), today announced that it will release its third quarter calendar year 2019 financial results on Wednesday, November 6, 2019. The Company will host a conference call beginning at 8:00 a.m. (EDT).
Oct 03, 2019 05:18 pm ET
Perrigo® Hosts 175 West Michigan Students for Manufacturing Week Celebration
ALLEGAN, Mich., Oct. 3, 2019 /PRNewswire/ -- Perrigo Company plc (NYSE; TASE: PRGO), a leading provider of "Quality Affordable Self-Care Products™", opened its doors for more than 175 high school students Thursday as part of Michigan Manufacturing Week.
Oct 03, 2019 08:00 am ET
Perrigo Announces the Relaunch of the AB Rated Generic Version of Transderm Scop® 1.5 MG
DUBLIN, Oct. 3, 2019 /PRNewswire/ -- Perrigo Company plc (NYSE; TASE: PRGO) today announced the relaunch of the AB rated generic equivalent of Transderm Scop® (scopolamine 1.5 mg). Annual market sales of Transderm Scop® and therapeutic equivalents for the 12 months ending August 2019 were approximately $147 million.
Sep 05, 2019 08:30 am ET
Perrigo Advances Consumer Self-Care Growth Strategy With Acquisition Of Prevacid®24hr
DUBLIN, Sept. 5, 2019 /PRNewswire/ -- Perrigo Company plc (NYSE; TASE: PRGO) announced today that it has entered into a definitive agreement to acquire the branded OTC rights to Prevacid® from GlaxoSmithKline. Under the terms of the agreement, Perrigo will have the exclusive rights to market, sell and distribute Prevacid®24HR in the United States OTC market. Financial terms of the agreement were not disclosed.
Aug 22, 2019 07:48 am ET
Perrigo To Present At Upcoming Investor Conferences
DUBLIN, Aug. 22, 2019 /PRNewswire/ -- Perrigo Company plc (NYSE; TASE: PRGO), today announced that CEO and President, Murray S. Kessler and CFO, Ray Silcock, will host one-on-one meetings at the Barclay's Global Consumer Staples Conference on September 5, 2019 in Boston.
Aug 21, 2019 08:42 am ET
Perrigo Announces Patent Litigation Settlement for the Generic Version of Nascobal® Nasal Spray
DUBLIN, Aug. 21, 2019 /PRNewswire/ -- Perrigo Company plc (NYSE; TASE: PRGO) today announced that it has settled its Hatch-Waxman litigation relating to Nascobal®  (Cyanocobalamin) Nasal Spray brought by Endo Pharmaceuticals Inc. Terms of the settlement are confidential.
Aug 07, 2019 04:50 pm ET
Perrigo Announces Resignation Of Jeffrey C. Smith From Its Board Of Directors
DUBLIN, Aug. 7, 2019 /PRNewswire/ -- Perrigo Company plc (NYSE; TASE: PRGO), a leading provider of "Quality Affordable Self-Care Products™", today announced that Jeffrey C. Smith, Managing Member, Chief Executive Officer, and Chief Investment Officer of Starboard Value LP, who has been a director since 2017, has resigned from Perrigo's Board of Directors effective August 7, 2019.
Jul 31, 2019 09:52 am ET
Perrigo Announces Quarterly Dividend
DUBLIN, July 31, 2019 /PRNewswire/ -- Perrigo Company plc (NYSE; TASE: PRGO), a leading global provider of "Quality, Affordable Self-care Products™", today announced that its Board of Directors declared a quarterly dividend of $0.21 per share, payable on September 17, 2019 to shareholders of record on August 30, 2019.
Jul 25, 2019 09:17 am ET
Perrigo Announces Second Quarter Calendar Year 2019 Earnings Date
DUBLIN, July 25, 2019 /PRNewswire/ -- Perrigo Company plc (NYSE; TASE: PRGO), today announced that it will release its second quarter calendar year 2019 financial results on Thursday, August 8, 2019. The Company will host a conference call beginning at 8 a.m. (EDT).
Jul 08, 2019 04:12 pm ET
Perrigo Completes Divestiture of Animal Health Business for $185 Million
DUBLIN, July 8, 2019 /PRNewswire/ -- Perrigo Company plc (NYSE; TASE: PRGO) today announced that it has completed the previously announced divestiture of its Animal Health business to PetIQ (NASDAQ: PETQ) for $185 million.
Jul 08, 2019 04:05 pm ET
PetIQ, Inc. Completes Acquisition of Perrigo Animal Health
PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today announced effective today, it has completed the previously announced acquisition of Perrigo Animal Health, a leading manufacturer of vet...
Jul 03, 2019 08:37 am ET
Perrigo Announces FDA Final Approval and Launch Of The AB-rated Generic Version Of Metrogel-Vaginal® Gel
DUBLIN, July 3, 2019 /PRNewswire/ -- Perrigo Company plc (NYSE; TASE: PRGO) today announced its product development partner received final approval from the U.S. Food and Drug Administration for its AB-rated Abbreviated New Drug Application ("ANDA") referencing Metrogel-Vaginal® (metronidazole vaginal gel 0.75%).  Perrigo will acquire full ownership of the ANDA under a pre-existing arrangement with its partner within 30 days and anticipates launching this product immediately thereafter.
Jul 02, 2019 08:51 am ET
Perrigo Completes Acquisition Of Ranir, Raises Guidance
DUBLIN, July 2, 2019 /PRNewswire/ -- Perrigo Company plc (NYSE; TASE: PRGO) today announced the successful completion of its acquisition of Ranir Global Holdings LLC ("Ranir"), the leading global store brand supplier of oral self-care products, for $750 million in cash. This transaction advances Perrigo's transformation to a consumer-focused, self-care company while enhancing its position as a global leader in consumer self-care solutions.
May 28, 2019 09:00 am ET
Sol-Gel Technologies Announces Seventh Agreement for Generic Product Candidates with Perrigo
Sol-Gel Technologies, Ltd. (NASDAQ: SLGL) (“Sol-Gel” or the “Company”), a clinical-stage dermatology company focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases, today...
May 22, 2019 04:45 pm ET
May 21, 2019 09:12 am ET
Perrigo Announces FDA Final Approval For AB Rated Generic Version Of Voltaren® Gel 1%
DUBLIN, May 21, 2019 /PRNewswire/ -- Perrigo Company plc (NYSE; TASE: PRGO) today announced its partner received final approval from the U.S. Food and Drug Administration for its AB rated Abbreviated New Drug Application (ANDA) referencing Voltaren® Gel, 1% (diclofenac sodium topical gel, 1%). Perrigo will acquire full ownership of the ANDA under a pre-existing arrangement with its partner within 30 days. The Company anticipates launching this product within the next two months.  
May 09, 2019 07:30 am ET
Perrigo Unveils Self-Care Transformation Plan, 2019 Guidance And Long-Term Growth Targets At Investor Day
DUBLIN, May 9, 2019 /PRNewswire/ -- Perrigo Company plc (NYSE; TASE: PRGO) today is holding its Investor Day at the New York Stock Exchange in New York City, outlining its strategy to drive long-term growth and build shareholder value. Chief Executive Officer and President Murray S. Kessler, along with several key members of his leadership team, will share the Company's strategic plan, vision, and financial objectives while introducing their priorities for transforming Perrigo from a healthcare company to a consumer self-care company.
May 09, 2019 07:25 am ET
Global Oral Care Leader Ranir® Agrees to be Acquired by Leading Global Self-Care Company Perrigo
GRAND RAPIDS, Mich., May 9, 2019 /PRNewswire/ -- Ranir, LLC, a leading global manufacturer of store brand and value brand oral care products under the Plackers® and REMBRANDT® trademarks, today announced it has entered into a definitive agreement to be acquired by Perrigo Company plc (NYSE; TASE: PRGO), a leading global provider of Quality, Affordable Self-Care Products™ for $750 million.
May 09, 2019 07:00 am ET
Perrigo To Expand Into Adjacent Self-Care Category By Acquiring Ranir Global Holdings LLC, The Leading Global Private Label Supplier Of Oral Self-Care Products
DUBLIN, May 9, 2019 /PRNewswire/ -- Perrigo Company plc (NYSE, TASE: PRGO) today announced that it has reached a definitive agreement to purchase privately-held Ranir Global Holdings LLC ("Ranir") in a transaction valued at $750 million on a cash-free, debt-free basis, or approximately $685 million net of cash tax benefits on a present value basis. Ranir is the largest private label oral care company globally, with a comprehensive portfolio of 300+ highly customized oral care solutions including power toothbrush heads, power toothbrush handles, whitening strips, manual toothbrushes, fl
May 08, 2019 04:09 pm ET
Perrigo To Divest Animal Health Business For $185 Million In Cash As Part Of Consumer Self-Care Transformation
DUBLIN, May 8, 2019 /PRNewswire/ -- Perrigo Company plc (NYSE; TASE: PRGO), today announced that it has reached a definitive agreement to sell its Animal Health business to PetIQ (NASDAQ: PETQ) in a transaction valued at $185 million in cash. This transaction is consistent with Perrigo's plans to transform itself into a consumer-focused, self-care company. 
May 08, 2019 04:05 pm ET
PetIQ, Inc. Reports Record First Quarter 2019 Financial Results
PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today reported financial results for the three months ended March 31, 2019. First Quarter 2019 Highlights Compared to Prior Year Period Record...
May 01, 2019 04:13 pm ET
Perrigo Announces First Quarter Calendar Year 2019 Earnings Date And Upcoming Conference Participation
DUBLIN, May 1, 2019 /PRNewswire/ -- Perrigo Company plc (NYSE; TASE: PRGO), today announced that it will release its first quarter calendar year 2019 financial results on May 8, 2019 after market close in the U.S. and will discuss the results and 2019 guidance at its Investor Day on May 9, 2019.
Apr 26, 2019 09:03 am ET
Perrigo Increases Its Dividend By 11%
DUBLIN, April 26, 2019 /PRNewswire/ -- Perrigo Company plc (NYSE; TASE: PRGO), today announced that the company's Board of Directors, consistent with its recently approved strategic plan to evolve to a consumer self-care company, approved an 11% increase to the company's quarterly dividend to $0.21 per share from $0.19 per share. This dividend increase marks the 16th consecutive year Perrigo has increased its dividend.
Apr 18, 2019 04:15 pm ET
Perrigo To Host Investor Day
DUBLIN, April 18, 2019 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO; TASE), a leading global provider of Quality, Affordable Self-Care Products™, today announced that it will hold its Investor Day on May 9 in New York City to discuss its strategy and key growth opportunities. The event will feature presentations from Murray S. Kessler, President and Chief Executive Officer, as well as members of the Company's leadership team. Due to limited capacity, attendance is by invitation only.
Apr 04, 2019 08:02 am ET
Perrigo Announces Tentative FDA Approval For The Generic Version Of Sernivo® Spray, 0.05%
DUBLIN, April 4, 2019 /PRNewswire/ -- Perrigo Company plc (NYSE; TASE: PRGO), a leading global provider of "Quality, Affordable, Self-Care Products™", today announced it has received tentative approval from the U.S. Food and Drug Administration for the generic version of Sernivo® (betamethasone dipropionate) Spray 0.05%. Perrigo previously settled its Hatch-Waxman litigation relating to Sernivo® (betamethasone dipropionate) Spray 0.05% brought by Promius Pharma LLC. Terms of the settlement remain confidential.
Apr 02, 2019 08:00 am ET
Perrigo Announces Patent Litigation Settlement For The Generic Version Of Finacea® Foam, 15%
DUBLIN, April 2, 2019 /PRNewswire/ -- Perrigo Company plc (NYSE; TASE: PRGO) a leading global provider of "Quality, Affordable, Self-Care Products™", today announced that it has settled its Hatch-Waxman litigation relating to its tentatively-approved generic version of Finacea® Foam (azelaic acid) 15% pursued by LEO Pharma A/S, LEO Pharma Inc., and Foamix Pharmaceuticals Ltd.  Terms of the settlement are confidential.
Mar 21, 2019 04:05 pm ET
Sol-Gel Technologies Reports Full Year 2018 Financial Results and Provides Corporate Update
Sol-Gel Technologies Ltd. (NASDAQ: SLGL) (“Sol-Gel” or the “Company”), a clinical-stage dermatology company focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases, today...
Mar 20, 2019 04:30 pm ET
Perrigo Appoints Seasoned CPG Veteran Ray Silcock As Chief Financial Officer
DUBLIN, March 20, 2019 /PRNewswire/ -- Perrigo Company plc (NYSE; TASE: PRGO) today announced that Ray Silcock will join the Company as Executive Vice President and Chief Financial Officer, effective March 25, 2019. Ray will lead the global finance, tax, internal audit, investor relations, corporate communications, business development and treasury functions. He will report to President and Chief Executive Officer, Murray S. Kessler.
Mar 18, 2019 04:30 pm ET
Perrigo Announces Tentative FDA Approval For The Generic Version Of Finacea® Foam, 15%
DUBLIN, March 18, 2019 /PRNewswire/ -- Perrigo Company plc (NYSE; TASE: PRGO) a leading global provider of "Quality, Affordable, Self-Care Products™" today announced it has received tentative approval from the U.S. Food and Drug Administration for the generic version of Finacea® Foam (azelaic acid) 15%.  Perrigo previously announced a patent litigation suit with Bayer AG for this product. Subsequently, LEO Pharma A/S acquired Finacea® Foam (azelaic acid) 15% from Bayer AG and then substituted for Bayer AG as the lead plaintiff in the patent litigation suit concerning the product. 
Mar 07, 2019 07:00 am ET
Recent Analysis Shows Veeva, Mobile TeleSystems OJSC, Jacobs Engineering Group, Perrigo Company plc, AstraZeneca, and Primoris Services Market Influences — Renewed Outlook, Key Drivers of Growth
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Veeva Systems Inc. (NYSE:VEEV), Mobile TeleSystems OJSC (NYSE:MBT), Jacobs...
Mar 05, 2019 07:52 am ET
Perrigo Confirms Patent Challenge for Generic Version of Nascobal®
DUBLIN, March 5, 2019 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO; TASE) today announced that Endo Pharmaceuticals Inc. initiated patent litigation on March 1, 2019 in the United States District Court for the District of Delaware regarding Perrigo's Paragraph IV Abbreviated New Drug Application for cyanocobalamin nasal spray 500mcg, asserting patents listed in the Orange Book for Nascobal®. This action formally initiates the litigation process under the Hatch-Waxman Act.
Mar 04, 2019 09:40 am ET
DEADLINE TODAY: UPDATE for YRCW, PRGO and YRIV: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the...
Mar 03, 2019 09:35 am ET
PERRIGO INVESTOR ALERT: Rosen Law Firm Reminds Perrigo Company plc Investors of Important March 4, 2019 Deadline in Securities Class Action Lawsuit – PRGO
Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Perrigo Company plc (NYSE: PRGO) from November 8, 2018 through December 20, 2018, inclusive (the “Class Period”) of the important March 4, 2019 deadline in the securities class action lawsuit filed against the company. The lawsuit seeks to recover damages for Perrigo investors under the federal securities laws.
Mar 01, 2019 04:12 pm ET
SHAREHOLDER ALERT: Pawar Law Group Announces a Securities Class Action Lawsuit Against Perrigo Company plc - March 4 Deadline – PRGO
Pawar Law Group announces that a class action lawsuit has been filed on behalf of shareholders who purchased shares of Perrigo Company plc (NYSE: PRGO) from November 8, 2018 through December 20, 2018, inclusive (the “Class Period”). The lawsuit...
Mar 01, 2019 11:04 am ET
SHAREHOLDER ALERT: DNKEY YRCW SOGO PRGO: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
The Law Offices of Vincent Wong announce that class actions have commenced on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead...
Feb 28, 2019 12:39 pm ET
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of YRCW, PRGO, AVEO and CVS
The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead...
Feb 27, 2019 03:01 pm ET
Feb 27, 2019 01:57 pm ET
FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of DNKEY, ARLO, SOGO and PRGO
The securities litigation law firm of Kuznicki Law PLLC issues the following notice on behalf of shareholders of the following publicly traded companies. Shareholders who purchased shares in these companies during the dates listed below are...
Feb 27, 2019 12:19 pm ET
CLASS ACTION UPDATE for PRGO, MKL, TYME and AVP: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the...
Feb 26, 2019 06:08 pm ET
CLASS ACTION UPDATE for PRGO, W, AMRN and VNDA: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the...
Feb 26, 2019 02:40 pm ET
CLASS ACTION UPDATE for YRCW, PRGO, VALE and AVP: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the...
Feb 26, 2019 10:26 am ET
FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of PRGO, MAXR, UXIN and TAP
The securities litigation law firm of Kuznicki Law PLLC issues the following notice on behalf of shareholders of the following publicly traded companies. Shareholders who purchased shares in these companies during the dates listed below are...
Feb 25, 2019 08:50 pm ET
EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Perrigo Company plc – PRGO
Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Perrigo Company plc (NYSE:PRGO) from November 8, 2018 through December 20, 2018, inclusive (the “Class Period”). The lawsuit seeks to recover damages for Perrigo investors under the federal securities laws.
Feb 25, 2019 06:55 pm ET
Block & Leviton LLP Files Securities Class Action Against Perrigo Company plc.; Investors Are Encouraged to Contact the Firm
Block & Leviton LLP (www.blockesq.com), a securities litigation firm representing investors nationwide, has filed a securities fraud class action against Perrigo Company plc. (“PRGO” or the “Company”) (NYSE: PRGO) and certain of its officers. The...
Feb 25, 2019 03:16 pm ET
FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of DNKEY, IMMU, PRGO and DXC
The securities litigation law firm of Kuznicki Law PLLC issues the following notice on behalf of shareholders of the following publicly traded companies. Shareholders who purchased shares in these companies during the dates listed below are...
Feb 25, 2019 02:19 pm ET
CLASS ACTION UPDATE for DNKEY, YRCW, PRGO and MU: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the...
Feb 25, 2019 11:27 am ET
CLASS ACTION UPDATE for PRGO, W, MKL and ASTE: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the...
Feb 25, 2019 07:37 am ET
Perrigo Receives Leave To Judicially Review Irish Revenue Tax Assessment
DUBLIN, Feb. 25, 2019 /PRNewswire/ -- Perrigo Company plc (NYSE; TASE: PRGO), a leading global provider of "Quality, Affordable, Self-Care Products™", today announced that its subsidiary, Perrigo Pharma International DAC ("Elan Pharma"), has been granted leave by the Irish High Court to judicially review the November 29, 2018 issuance of a Notice of Amended Assessment by the Irish Office of the Revenue Commissioners for the calendar year ended December 31, 2013.
Feb 24, 2019 07:00 pm ET
CLASS ACTION UPDATE for PRGO, VALE, SVXY and MHLD: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the...
Feb 24, 2019 01:00 pm ET
CLASS ACTION UPDATE for YOGA, YRCW, PRGO and SVXY: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the...
Feb 24, 2019 11:00 am ET
CLASS ACTION UPDATE for PRGO, MU, ASTE and MHLD: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the...
Feb 22, 2019 05:26 pm ET
CLASS ACTION UPDATE for DNKEY, YOGA, PRGO and MAXR: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the...
Feb 22, 2019 01:59 pm ET
CLASS ACTION UPDATE for PRGO, MU, MHLD and AVP: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the...
Feb 22, 2019 01:35 pm ET
Deadline Reminder: The Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Perrigo Company plc (PRGO)
Law Offices of Howard G. Smith reminds investors of the March 4, 2019 deadline to file a lead plaintiff motion in the class action filed on behalf of investors that purchased Perrigo Company plc (“Perrigo” or the “Company”) (NYSE: PRGO) securities...
Feb 22, 2019 11:50 am ET
CLASS ACTION UPDATE for YRCW, PRGO, AXGN and VALE: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the...
Feb 22, 2019 07:30 am ET
CLASS ACTION UPDATE for PRGO, DBVT, ALKS and W: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the...
Feb 21, 2019 01:57 pm ET
FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of SOGO, PRGO, AXGN and GE
The securities litigation law firm of Kuznicki Law PLLC issues the following notice on behalf of shareholders of the following publicly traded companies. Shareholders who purchased shares in these companies during the dates listed below are...
Feb 21, 2019 11:09 am ET
CLASS ACTION UPDATE for PRGO, ATVI, UXIN and AVP: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the...
Feb 20, 2019 07:32 pm ET
CLASS ACTION UPDATE for PRGO, AXGN, MKL and MAXR: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the...
Feb 20, 2019 04:22 pm ET
Block & Leviton LLP Reminds Shareholders of Important Deadlines; IMMU, PRGO, YRC, W
Block & Leviton LLP (www.blockesq.com), a securities litigation firm representing investors nationwide, reminds investors of the important deadlines listed below. If you have purchased or otherwise acquired any of the securities listed below,...
Feb 20, 2019 02:09 pm ET
CLASS ACTION UPDATE for PRGO, MKL, ATVI and MU: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the...
Feb 20, 2019 11:51 am ET
FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of PRGO, MAXR, GSM and SVXY
The securities litigation law firm of Kuznicki Law PLLC issues the following notice on behalf of shareholders of the following publicly traded companies. Shareholders who purchased shares in these companies during the dates listed below are...
Feb 20, 2019 07:15 am ET
CLASS ACTION UPDATE for SOGO, PRGO, DBVT and DXC: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the...
Feb 19, 2019 07:00 pm ET
CLASS ACTION UPDATE for ARLO, PRGO, ALKS and ASTE: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the...
Feb 19, 2019 04:30 pm ET
CLASS ACTION UPDATE for SOGO, PRGO, DBVT and DXC: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the...
Feb 19, 2019 02:17 pm ET
Block & Leviton LLP Reminds Shareholders of Important Deadlines; IMMU, PRGO, YRC, NHTC
Block & Leviton LLP (www.blockesq.com), a securities litigation firm representing investors nationwide, reminds investors of the important deadlines listed below. If you have purchased or otherwise acquired any of the securities listed below,...
Feb 19, 2019 01:15 pm ET
CLASS ACTION UPDATE for DNKEY, PRGO, ASTE and TAP: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the...
Feb 19, 2019 11:42 am ET
FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of YOGA, PRGO, NVDA and GE
The securities litigation law firm of Kuznicki Law PLLC issues the following notice on behalf of shareholders of the following publicly traded companies. Shareholders who purchased shares in these companies during the dates listed below are...
Feb 19, 2019 10:33 am ET
CLASS ACTION UPDATE for IMMU, PRGO, ALKS and VALE: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the...
Feb 18, 2019 04:30 pm ET
CLASS ACTION UPDATE for DNKEY, YRCW and PRGO: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the...
Feb 18, 2019 10:11 am ET
FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of YOGA, PRGO, NVDA and GE
The securities litigation law firm of Kuznicki Law PLLC issues the following notice on behalf of shareholders of the following publicly traded companies. Shareholders who purchased shares in these companies during the dates listed below are...
Feb 18, 2019 07:10 am ET
CLASS ACTION UPDATE for GS, ARLO, PRGO and ALKS: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the...
Feb 17, 2019 02:00 pm ET
CLASS ACTION UPDATE for YOGA, PRGO, NVDA and UXIN: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the...
Feb 15, 2019 05:00 pm ET
CLASS ACTION UPDATE for PRGO, AXGN, YRIV and W: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the...
Feb 15, 2019 11:00 am ET
FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of DNKEY, SOGO, PRGO and DXC
The securities litigation law firm of Kuznicki Law PLLC issues the following notice on behalf of shareholders of the following publicly traded companies. Shareholders who purchased shares in these companies during the dates listed below are...
Feb 15, 2019 09:46 am ET
CLASS ACTION UPDATE for GS, PRGO, W and GSM: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the...
Feb 14, 2019 06:11 pm ET
CLASS ACTION UPDATE for ARLO, PRGO, DBVT and VALE: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the...
Feb 14, 2019 03:08 pm ET
CLASS ACTION UPDATE for PRGO, DXC and GSM: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the...
Feb 14, 2019 01:30 pm ET
FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of XRAY, PRGO, ASTE and UXIN
The securities litigation law firm of Kuznicki Law PLLC issues the following notice on behalf of shareholders of the following publicly traded companies. Shareholders who purchased shares in these companies during the dates listed below are...
Feb 14, 2019 08:05 am ET
Perrigo Announces Quarterly Dividend
DUBLIN, Feb. 14, 2019 /PRNewswire/ -- Perrigo Company plc (NYSE; TASE: PRGO), a leading global provider of "Quality, Affordable Self-care Products™", today announced that its Board of Directors declared a quarterly dividend of $0.19 per share, payable on March 19, 2019 to shareholders of record on March 1, 2019.
Feb 13, 2019 08:00 pm ET
CLASS ACTION UPDATE for SOGO, PRGO, AGN and ALKS: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the...
Feb 13, 2019 03:57 pm ET
FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of SOGO, PRGO, AGN and ALKS
The securities litigation law firm of Kuznicki Law PLLC issues the following notice on behalf of shareholders of the following publicly traded companies. Shareholders who purchased shares in these companies during the dates listed below are...
Feb 13, 2019 02:42 pm ET
LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In Perrigo Company plc To Contact The Firm
Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Perrigo Company plc ("Perrigo" or the "Company") (NYSE:PRGO) of the March 4, 2019 deadline to seek the role of lead plaintiff in a federal securities class action...
Feb 13, 2019 10:10 am ET
CLASS ACTION UPDATE for PRGO, YRIV, ALKS and MU: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the...
Feb 13, 2019 08:22 am ET
Perrigo Announces Patent Litigation Settlement for the Generic Version of Jublia® Topical Solution 10%
DUBLIN, Feb. 13, 2019 /PRNewswire/ -- Perrigo Company plc (NYSE; TASE: PRGO), a leading global provider of "Quality, Affordable Self-care Products™", today announced that it has settled its Hatch-Waxman litigation relating to its first-to-file Abbreviated New Drug Application for the generic equivalent to Jublia® (efinaconazole) Topical Solution 10% brought by Valeant Pharmaceuticals North America LLC, Valeant Pharmaceuticals Ireland LTD., Dow Pharmaceuticals Sciences, Inc., and Kaken Pharmaceuticals Co., LTD. Terms of the settlement are confidential.
Feb 13, 2019 07:43 am ET
Perrigo Company plc To Release Fourth Quarter And Calendar Year 2018 Results On February 27, 2019
DUBLIN, Feb. 13, 2019 /PRNewswire/ -- Perrigo Company plc (NYSE; TASE: PRGO), a leading global provider of "Quality, Affordable Self-care Products™", today announced that it will release its fourth quarter and calendar year 2018 financial results on Wednesday, February 27, 2019. The Company will host a conference call beginning at 4:30 p.m. (EST).
Feb 12, 2019 02:00 pm ET
FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of XPO, PRGO, NVDA and ATVI
The securities litigation law firm of Kuznicki Law PLLC issues the following notice on behalf of shareholders of the following publicly traded companies. Shareholders who purchased shares in these companies during the dates listed below are...
Feb 11, 2019 04:59 pm ET
CLASS ACTION UPDATE for PRGO, NVDA, AGN and ASTE: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the...
Feb 11, 2019 01:50 pm ET
CLASS ACTION UPDATE for TDOC, ARLO, PRGO and MAXR: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the...
Feb 11, 2019 01:00 pm ET
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Perrigo Company plc (PRGO), Liberty Health Sciences Inc. (LHSIF) and China TechFaith Wireless Communicat
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you may...
Feb 08, 2019 12:52 pm ET
FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of XPO, XRAY, PRGO and NVDA
The securities litigation law firm of Kuznicki Law PLLC issues the following notice on behalf of shareholders of the following publicly traded companies. Shareholders who purchased shares in these companies during the dates listed below are...
Feb 08, 2019 10:33 am ET
CLASS ACTION UPDATE for PRGO, AXGN, AGN and TYME: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the...
Feb 07, 2019 03:28 pm ET
CLASS ACTION UPDATE for ARLO, XRAY, PRGO and AGN: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the...

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.